Sensei Biotherapeutics, Inc.
SNSE
Revenue
0.00
0.000.00%
-Assets
59.80M
▼-6.90M▼-10.34%
3 Months ChangeLiabilities
7.61M
▼-614.00k▼-7.47%
3 Months ChangeFree Cash Flow
-7.65M
▲4.23M▲35.62%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001193125-24-247599
2024-09-20
Form 8-K
ID: 0001193125-24-222937
2024-08-06
Form 10-Q
ID: 0000950170-24-091895
2024-08-06
Form 8-K
ID: 0001193125-24-194428
2024-07-12
Form 8-K
ID: 0001193125-24-178607
2024-06-27
Form 8-K
ID: 0001193125-24-170690
2024-06-13
Form 8-K
ID: 0001193125-24-160769
2024-06-03
Form 8-K
ID: 0001193125-24-152363
2024-05-23
Form 8-K
ID: 0001193125-24-146093
2024-05-09
Form 10-Q
ID: 0000950170-24-057106